Jeff is deputy chief editor of Outsourced Pharma, where he translates complex biology and manufacturing into practical guidance for drug sponsors navigating CDMO selection, tech transfer, analytics, and timelines. He holds a PhD in Molecular Cell Biology from Thomas Jefferson University and a BS in Biology from the University of the Sciences in Philadelphia. His editorials reflect two decades spanning bench science, publishing, and industry, and are written to help readers see both the big-picture dynamics and on-the-ground realities of outsourcing. Prior to Outsourced Pharma, Jeff served as the technical editor at Genetic Engineering & Biotechnology News (GEN), where he authored features and hosted GEN’s “GenCast” podcast series and managed multimedia initiatives at Mary Ann Liebert Publishing. Afterwards, he engaged audiences with his editorial leadership as Director of Content at SynBioBeta. Earlier in his career, he conducted postdoctoral research in molecular microbiology at Washington University in St. Louis, publishing on parasite invasion mechanisms, including a widely cited Toxoplasma gondii study on the rhomboid protease ROM4. These experiences inform his science-minded, operations-aware voice across the outsourcing lifecycle.

Jeff is an avid Philly sports fan, homebrewer, and foodie.